Skip to main content
Article
Effect of erythrocytes of androgens on 2,3-diphosphoglycerate in patients with chronic obstructive pulmonary disease
Chest
  • John P. Simelaro, Philadelphia College of Osteopathic Medicine
  • Michael Venditto, Philadelphia College of Osteopathic Medicine
  • M. Ghens
Document Type
Article
Publication Date
1-1-1980
Abstract
Because androgen therapy is known to increase 2,3-diphosphoglycerate in the erythrocytes of patients with chronic renal failure, the possibility that it might have a similar effect on patients with chronic obstructive pulmonary disease appeared worth investigating. Results of a small study appear promising, with improvement in stress tolerance and general well-being. Pulmonary function was not improved, and the severity of pulmonary disease was not affected, but further investigation of the treatment appears to be warranted.
Comments

This article was published in Chest, Volume 76, Issue 2, Pages 240-241.

The published version is not available online.

Citation Information
John P. Simelaro, Michael Venditto and M. Ghens. "Effect of erythrocytes of androgens on 2,3-diphosphoglycerate in patients with chronic obstructive pulmonary disease" Chest Vol. 76 Iss. 2 (1980) p. 240 - 241
Available at: http://works.bepress.com/john_simelaro/8/